Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Severe COVID-19 in Uganda across Two Epidemic Phases: A Prospective Cohort Study.
Bakamutumaho B, Cummings MJ, Owor N, Kayiwa J, Namulondo J, Byaruhanga T, Muwanga M, Nsereko C, Rwamutwe E, Mutonyi R, Achan J, Wanyenze L, Ndazarwe A, Nakanjako R, Natuhwera R, Nsangi A, Bosa HK, Ocom F, O'Donnell MR, Kikaire B, Lutwama JJ; Collaboration for Clinical and Laboratory Characterization of COVID-19 in Uganda. Bakamutumaho B, et al. Among authors: kikaire b. Am J Trop Med Hyg. 2021 Aug 9;105(3):740-744. doi: 10.4269/ajtmh.21-0551. Am J Trop Med Hyg. 2021. PMID: 34370701 Free PMC article.
Field evaluation of the performance of a SARS-CoV-2 antigen rapid diagnostic test in Uganda using nasopharyngeal samples.
Nalumansi A, Lutalo T, Kayiwa J, Watera C, Balinandi S, Kiconco J, Nakaseegu J, Olara D, Odwilo E, Serwanga J, Kikaire B, Ssemwanga D, Nabadda S, Ssewanyana I, Atwine D, Mwebesa H, Bosa HK, Nsereko C, Cotten M, Downing R, Lutwama J, Kaleebu P. Nalumansi A, et al. Among authors: kikaire b. Int J Infect Dis. 2021 Mar;104:282-286. doi: 10.1016/j.ijid.2020.10.073. Epub 2020 Oct 30. Int J Infect Dis. 2021. PMID: 33130198 Free PMC article.
Evaluation of the performance of 25 SARS-CoV-2 serological rapid diagnostic tests using a reference panel of plasma specimens at the Uganda Virus Research Institute.
Lutalo T, Nalumansi A, Olara D, Kayiwa J, Ogwang B, Odwilo E, Watera C, Balinandi S, Kiconco J, Nakaseegu J, Serwanga J, Kikaire B, Ssemwanga D, Abiko B, Nsereko C, Cotten M, Buule J, Lutwama J, Downing R, Kaleebu P. Lutalo T, et al. Among authors: kikaire b. Int J Infect Dis. 2021 Nov;112:281-287. doi: 10.1016/j.ijid.2021.09.020. Epub 2021 Sep 15. Int J Infect Dis. 2021. PMID: 34536612 Free PMC article.
Epidemiology, Clinical Characteristics, and Mortality of Hospitalized Patients with Severe COVID-19 in Uganda, 2020-2021.
Bakamutumaho B, Lutwama JJ, Owor N, Kayiwa J, Kiconco J, Haumba M, Muwanga M, Nsereko C, Rwamutwe E, Nayiga I, Kyebambe S, Kyobe Bosa H, Ocom F, Watyaba B, Kikaire B, Kisaka S, Kiwanuka N, O'Donnell MR, Cummings MJ; Members of the Collaboration for Clinical and Laboratory Characterization of COVID-19 in Uganda. Bakamutumaho B, et al. Among authors: kikaire b. Ann Am Thorac Soc. 2022 Dec;19(12):2100-2103. doi: 10.1513/AnnalsATS.202203-244RL. Ann Am Thorac Soc. 2022. PMID: 35727227 Free PMC article. No abstract available.
COVID-19 immune signatures in Uganda persist in HIV co-infection and diverge by pandemic phase.
Cummings MJ, Bakamutumaho B, Lutwama JJ, Owor N, Che X, Astorkia M, Postler TS, Kayiwa J, Kiconco J, Muwanga M, Nsereko C, Rwamutwe E, Nayiga I, Kyebambe S, Haumba M, Bosa HK, Ocom F, Watyaba B, Kikaire B, Tomoiaga AS, Kisaka S, Kiwanuka N, Lipkin WI, O'Donnell MR; Collaboration for Clinical and Laboratory Characterization of COVID-19 in Uganda. Cummings MJ, et al. Among authors: kikaire b. Nat Commun. 2024 Feb 17;15(1):1475. doi: 10.1038/s41467-024-45204-3. Nat Commun. 2024. PMID: 38368384 Free PMC article.
HIV viral load suppression following intensive adherence counseling among people living with HIV on treatment at military-managed health facilities in Uganda.
Kikaire B, Ssemanda M, Asiimwe A, Nakanwagi M, Rwegyema T, Seruwagi G, Lawoko S, Asiimwe E, Wamundu C, Musinguzi A, Lugada E, Turesson E, Laverentz M, Bwayo D. Kikaire B, et al. Int J Infect Dis. 2021 Nov;112:45-51. doi: 10.1016/j.ijid.2021.08.057. Epub 2021 Sep 2. Int J Infect Dis. 2021. PMID: 34481969 Free article.
Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Munderi P, Walker AS, Kityo C, Babiker AG, Ssali F, Reid A, Darbyshire JH, Grosskurth H, Mugyenyi P, Gibb DM, Gilks CF; DART/NORA trial teams. Munderi P, et al. HIV Med. 2010 May;11(5):334-44. doi: 10.1111/j.1468-1293.2009.00786.x. Epub 2010 Feb 3. HIV Med. 2010. PMID: 20136661 Free article. Clinical Trial.
Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial.
Parikh SM, Obuku EA, Walker SA, Semeere AS, Auerbach BJ, Hakim JG, Mayanja-Kizza H, Mugyenyi PN, Salata RA, Kityo CM; DART Trial Team. Parikh SM, et al. PLoS One. 2013 Oct 2;8(10):e76158. doi: 10.1371/journal.pone.0076158. eCollection 2013. PLoS One. 2013. PMID: 24098434 Free PMC article. Clinical Trial.
35 results